1. Home
  2. Inspections, Compliance, Enforcement, and Criminal Investigations
  3. Compliance Actions and Activities
  4. Warning Letters
  1. Compliance Actions and Activities

Warning Letters

Learn about the types of warning letters on FDA's website.

  • Matters described in FDA warning letters may have been subject to subsequent interaction between FDA and the letter recipient that may have changed the regulatory status of issues discussed in the letter.
  • To obtain additional available information, contact FDA. Requests to FDA for agency records should be sent to: Food and Drug Administration Division of Freedom of Information (HFI-35), 5630 Fishers Lane, Rockville, MD 20857. Instructions for how to submit an FOI request can be found at How to Make a FOIA Request.
  • Frequently requested records may be accessed on the Reading Room page.

 


Posted Date Letter Issue Date Company Name Issuing Office Subject Response Letter Closeout Letter Excerpt
Dabur India Limited Center for Drug Evaluation and Research (CDER) CGMP/Finished Pharmaceuticals/Adulterated
Woodbine Products Company Inc. Center for Drug Evaluation and Research (CDER) CGMP/Finished Pharmaceuticals/Adulterated
ABS Corporation Center for Veterinary Medicine CGMP/Finished Pharmaceuticals/Adulterated
Friend’s Stable and Orchard, Inc. Human Foods Program Food/Prepared Packed or Held Under Insanitary Conditions/Adulterated
Maria E. De La Torre Silva, M.D. Center for Drug Evaluation and Research (CDER) Clinical Investigator
Koven Technologies, Inc. Center for Devices and Radiological Health CGMP/QSR/Medical Devices/Adulterated
AAL Trading Inc. Office of Inspections and Investigations Foreign Supplier Verification Program (FSVP)
Thomas Brunner Hygiene GmbH Center for Drug Evaluation and Research (CDER) CGMP/Finished Pharmaceuticals/Unapproved New Drug/Misbranded/Adulterated
AHC Products, Inc. Center for Veterinary Medicine CGMP/Finished Pharmaceuticals/Adulterated
Eherbs Imports, Inc Office of Inspections and Investigations Foreign Supplier Verification Program (FSVP)

SUBSCRIBE

Get regular FDA email updates delivered on this topic to your inbox.
Back to Top